Synapse - Works

Results (4808)

Refractory T-cell prolymphocytic leukemia with JAK3 mutation: In vitro and clinical synergy of tofacitinib and ruxolitinib

Meeting Abstract

Wei, M.; Koshy, N.; van Besien, K.; Inghirami, G.; Horwitz, S. M.
Blood (2015)

Fulltext@MSK | Save

The finding of Del 17p in marrow plasma cells from patients with light-chain amyloidosis (AL) may confer a worse prognosis

Meeting Abstract

Wong, S. W.; Palladini, G.; Hegenbart, U.; Landau, H.; Warner, M.; Jaccard, A.; Avet-Loiseau, H.; Hansen, T.; Blade, J.; Cibeira, M. T.; more...
Blood (2015)

Fulltext@MSK | Save

Phase 1b study of PD-1 blockade with pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma (PMBCL)

Meeting Abstract

Zinzani, P. L.; Ribrag, V.; Moskowitz, C. H.; Michot, J. M.; Kuruvilla, J.; Balakumaran, A.; Snyder, E.; Marinello, P.; Shipp, M. A.; Armand, P.
Blood (2015)

Fulltext@MSK | Save

A hyperactive signalosome results in high sensitivity to HSP90 inhibitors in AML

Meeting Abstract

Zong, H. L.; Taldone, T.; Roboz, G. J.; Chiosis, G.; Guzman, M. L.
Blood (2015)

Fulltext@MSK | Save

Astarabine, a pro-drug of cytarabine, is safe for patients with advanced acute leukemia. A phase I/IIa single center study in relapsed/refractory or medically unfit patients

Meeting Abstract

Zuckerman, T.; Ben Yakar, R.; Gengrinovitch, S.; Hoffman, R.; Henig, I.; Lavi, N.; Akria, L.; Ofran, Y.; Nudelman, O.; Haddad, N.; more...
Blood (2015)

Fulltext@MSK | Save

SH2B3/LNK loss of function promotes atherosclerosis and thrombosis

Meeting Abstract

Wang, W.; Tang, Y.; Wang, Y.; Balcerek, J.; Tong, W.; Levine, R. L.; Welch, C.; Tall, A.; Wang, N.
Blood (2015)

Fulltext@MSK | Save

Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era

Meeting Abstract

Vardhana, S. A.; Moskowitz, C. H.; Sauter, C. S.; Matasar, M. J.; Galasso, N.; Woo, K. M.; Zhang, Z. G.
Blood (2015)

Fulltext@MSK | Save

Impact of busulphan exposure on transplant outcomes for patients with advanced myelodysplastic syndromes undergoing CD34 selected allogeneic hematopoietic cell transplantation

Meeting Abstract

Tamari, R.; Proli, A.; Zheng, J. T.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; Devlin, S.; Sauter, C. S.; Young, J. W.; Giralt, S. A.; more...
Blood (2015)

Fulltext@MSK | Save

Reduced emergency room utilization for initiation of anticoagulation with rivaroxaban versus Low Molecular Weight Heparin for treatment of cancer-associated thrombosis

Meeting Abstract

Soff, A. P.; Dong, J.; Dong, A.; Devlin, S.; Mantha, S.; Parameswaran, R.; Soff, G. A.
Blood (2015)

Fulltext@MSK | Save

A phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in adults with relapsed or refractory leukemia: Safety, clinical activity, exposure and target inhibition

Meeting Abstract

Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Tibes, R.; Berdeja, J. G.; Jongen-Lavrencic, M.; Altman, J. K.; Dohner, H.; Thomson, B.; Blakemore, S. J.; more...
Blood (2015)

Fulltext@MSK | Save